(Refiles to add media packaging code)
(Reuters) -Novavax Inc said on Thursday it had received provisional approval from New Zealand’s medicines regulator for its COVID-19 vaccine, Nuvaxovid, for individuals 18 years of age and older.
(Reporting by Amruta Khandekar; Editing by Anil D’Silva)